LLY Research and Charts

LLY - Eli Lilly and Co (Healthcare: Drug Manufacturers - General)

Projected Earnings Date: 2026-05-06 (Delayed quote data 2026-02-10)

Last 1024.66	Change ⇓ -19.66 (-1.88%)	Volume 3,534,935
	Open 1050.93	High 1055.65	Low 1023.88

8EMA (Daily) 1041.73	40EMA (Daily) 1041.57	50EMA (Daily) 1032.51	STO (Daily) 47.658	MACD Hist (Daily) -0.715
8EMA (Weekly) 1040.944	40EMA (Weekly) 920.68	50EMA (Weekly) 899.87	STO (Weekly) 67.693	MACD Hist (Weekly) -14.153


Company Profile
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, oncology, and immunology. Lilly's key products include Alimta and Verzenio for cancer; Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.